Clinical trial
A Randomized Controlled Trial Evaluating the Efficacy of Conditioned Open Label Placebo (COLP) to Limit Opioid Reliance for Postoperative Pain Management
NCT06107595 is registered in ClinicalTrials.gov with Centre de Médecine Intégrative et Complémentaire (CEMIC) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Trial Evaluating the Efficacy of Conditioned Open Label Placebo (COLP) to Limit Opioid Reliance for Postoperative Pain Management
- Lead sponsor
- Centre de Médecine Intégrative et Complémentaire (CEMIC)
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 8, 2024
- Completion date
- December 31, 2025
- Enrollment
- 222 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pain, postoperative